Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056013 · ClinicalTrials.gov registry record · NA
Vicryl Rapide Versus Nonabsorbable Suture
A NA study of Traumatic Lacerations, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 2
- Study locations
NCT04056013: Recruiting NA study of Traumatic Lacerations, sponsored by University of California, San Francisco.
NCT04056013 is a NA study of Traumatic Lacerations that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04056013, a NA study of Traumatic Lacerations, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 2
- Study locations
Study Summary
This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month cosmesis for traumatic laceration repair of trunk/extremity lacerations in adult patients with Vicryl Rapide is noninferior to nonabsorbable suture.
Primary Outcome
For sample size determination, based on a previous study, we expected that the standard deviation (SD) for cosmesis scores would be 15 mm.10 With the minimum clinically important cosmetic difference of 12-mm, and assuming an alpha value of 0.05 and statistical power of 90%, we estimated that we would need 46 subjects in each group for a total of 96 patients (assuming a dropout rate of 40%), to detect this 12-mm difference in the groups' mean cosmesis scores.
Conditions Studied
Interventions
- DEVICE Vicryl Rapide absorbable suture
Study Locations (2)
California
- Community Regional Medical Center - Fresno
- Community Regional Trauma and Burn Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
What NCT04056013 shows while recruiting
NCT04056013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Traumatic Lacerations appearing as the primary indexed condition, and to 1 intervention - of which Vicryl Rapide absorbable suture is the first listed.
NCT04056013 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04056013 about?
NCT04056013 is a clinical study titled "Vicryl Rapide Versus Nonabsorbable Suture". This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month co...
What is the current status of trial NCT04056013?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2019-09-26. Estimated completion is 2029-01-31.
What conditions does trial NCT04056013 study?
This clinical trial studies the following conditions: Traumatic Lacerations.
What interventions are being tested in trial NCT04056013?
The interventions under investigation include: Vicryl Rapide absorbable suture (DEVICE).
Who is sponsoring clinical trial NCT04056013?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04056013 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04056013's enrollment target sits among peer trials
96 926th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI